Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 May 15;105(10):3848-54.
doi: 10.1182/blood-2004-04-1472. Epub 2005 Feb 1.

PIG-A mutations in normal hematopoiesis

Affiliations

PIG-A mutations in normal hematopoiesis

Rong Hu et al. Blood. .

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is caused by phosphatidylinositol glycan-class A (PIG-A) mutations in hematopoietic stem cells (HSCs). PIG-A mutations have been found in granulocytes from most healthy individuals, suggesting that these spontaneous PIG-A mutations are important in the pathogenesis of PNH. It remains unclear if these PIG-A mutations have relevance to those found in PNH. We isolated CD34+ progenitors from 4 patients with PNH and 27 controls. The frequency of PIG-A mutant progenitors was determined by assaying for colony-forming cells (CFCs) in methylcellulose containing toxic doses of aerolysin (1 x 10(-9) M). Glycosylphosphatidylinositol (GPI)-anchored proteins serve as receptors for aerolysin; thus, PNH cells are resistant to aerolysin. The frequency of aerolysin resistant CFC was 14.7 +/- 4.0 x 10(-6) in the bone marrow of healthy donors and was 57.0 +/- 6.7 x 10(-6) from mobilized peripheral blood. DNA was extracted from individual day-14 aerolysin-resistant CFCs and the PIG-A gene was sequenced to determine clonality. Aerolysin-resistant CFCs from patients with PNH exhibited clonal PIG-A mutations. In contrast, PIG-A mutations in the CFCs from controls were polyclonal, and did not involve T cells. Our data confirm the finding that PIG-A mutations are relatively common in normal hematopoiesis; however, the finding suggests that these mutations occur in differentiated progenitors rather than HSCs.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic representation of the PIG-A gene and PCR primers. □ and ▪ represent coding and noncoding regions, respectively; arrows, PCR primer sites; and —, introns.
Figure 2.
Figure 2.
Flow cytometric analysis of pooled aerolysin-resistant colonies. Day-14 BFU-Es (top row) or CFU-GMs (bottom row) were washed from methycellulose-containing plates. BFU-Es were stained with FITC-conjugated anti–glycophorin-A and PE-conjugated anti-CD59. CFU-GMs were stained with PE-conjugated anti-CD15 and FLAER. Vertical and horizontal axes represent fluorescence intensity compared with isotypic controls.
Figure 3.
Figure 3.
Characterization of aerolysin resistant T-cell clones. (A) Flow cytometric analysis of pooled aerolysin-resistant T-cell clones. Day-16 colonies were washed and stained with FLAER. — represents expanded T-cell clones grown without aerolysin; –, expanded T-cell clones grown in the presence of aerolysin. (B) Mutation from CFU-GM/AE 9/7 lost MslI restriction site, which is CACAA′GGATG. Thus, MslI was used to screen aerolysin-enriched T-cell clones grown from the same donor. A total of 8 aerolysin-resistant T-cell clones were individually plucked and genomic DNA was extracted. A representative example is shown. Exon 4 of the PIG-A gene was amplified with the proofreading polymerase Pfu Ultra using the primers shown in Figure 1 and Table 1. The products were purified and digested with MslI. The PCR product from CFU-GM/AE 9/7 (lane P) which serves as a positive control were mixed in a 1:1 ratio with the normal allele, because the PIG-A gene is on the X chromosome and the X chromosome is randomly inactived in females. The TF1 cell line (lane C) serves as a normal control. Lane U represents uncut DNA from the T-cell clone and lane T shows the consequence of the Ms1I digest of DNA from a representative T-cell clone. M indicates molecular size markers.

References

    1. Rosse WF. Paroxysmal nocturnal hemoglobinuria as a molecular disease. Medicine. 1997;76: 63-93. - PubMed
    1. Nishimura J, Murakami Y, Kinoshita T. Paroxysmal nocturnal hemoglobinuria: an acquired genetic disease. Am J Hematol. 1999;62: 175-182. - PubMed
    1. Moyo VM, Mukhina GL, Garrett ES, Brodsky RA. Natural history of paroxysmal nocturnal hemoglobinuria using modern diagnostic assays. Br J Haematol. 2004;126: 133-138. - PubMed
    1. Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73: 703-711. - PubMed
    1. Bessler M, Mason PJ, Hillmen P, et al. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J. 1994;13: 110-117. - PMC - PubMed

Publication types